ELISA Kit for Suppression Of Tumorigenicity 14 (ST14)

SNC19; HAI; MT-SP1; PRSS14; TADG15; Epithin; Matriptase; Prostamin; Membrane-type serine protease 1; Serine protease 14; Tumor-associated differentially-expressed gene 15

  • ELISA Kit for Suppression Of Tumorigenicity 14 (ST14) Packages (Simulation)
  • ELISA Kit for Suppression Of Tumorigenicity 14 (ST14) Packages (Simulation)
  • ELISA Kit for Suppression Of Tumorigenicity 14 (ST14) Results demonstration
  • SEP657Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the ELISA Kit for Suppression Of Tumorigenicity 14 (ST14)

This assay has high sensitivity and excellent specificity for detection of Suppression Of Tumorigenicity 14 (ST14).
No significant cross-reactivity or interference between Suppression Of Tumorigenicity 14 (ST14) and analogues was observed.

Precision of the ELISA Kit for Suppression Of Tumorigenicity 14 (ST14)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Suppression Of Tumorigenicity 14 (ST14) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Suppression Of Tumorigenicity 14 (ST14) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Stability of the ELISA Kit for Suppression Of Tumorigenicity 14 (ST14)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the ELISA Kit for Suppression Of Tumorigenicity 14 (ST14)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

Test principle of the ELISA Kit for Suppression Of Tumorigenicity 14 (ST14)

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Suppression Of Tumorigenicity 14 (ST14). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Suppression Of Tumorigenicity 14 (ST14). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Suppression Of Tumorigenicity 14 (ST14), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Suppression Of Tumorigenicity 14 (ST14) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPP657Hu01 Recombinant Suppression Of Tumorigenicity 14 (ST14) Positive Control; Immunogen; SDS-PAGE; WB.
PAP657Hu02 Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14) WB; IHC; ICC; IP.
PAP657Hu01 Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14) WB; IHC; ICC; IP.
LAP657Hu81 FITC-Linked Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14) WB; IHC; ICC; IF.
LAP657Hu71 Biotin-Linked Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14) WB; IHC; ICC.
MAP657Hu21 Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14) WB; IHC
LAP657Hu72 Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14) WB; IHC; ICC.
SEP657Hu ELISA Kit for Suppression Of Tumorigenicity 14 (ST14) Enzyme-linked immunosorbent assay for Antigen Detection.
LMP657Hu Multiplex Assay Kit for Suppression Of Tumorigenicity 14 (ST14) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
PSP657Hu01 Antibody Pair for Suppression Of Tumorigenicity 14 (ST14) ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSP657Hu01 ELISA Kit DIY Materials for Suppression Of Tumorigenicity 14 (ST14) Main materials for "Do It (ELISA Kit) Yourself".
GUESTBOOK